A. Bowman

Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: Results of a double-blind, randomised trial

John F. Smyth, A. Bowman, Timothy Perren et al. · Annals of Oncology · 1997 · 177 citations · Full text

Medicine, Cancer Management, Pharmacology +8

Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04)

Robert E. Coleman, Michelle Collinson, Walter M. Gregory et al. · Journal of bone oncology · 2018 · 100 citations · Full text

Phase I and pharmacokinetic study of Yondelis™ (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours

Chris Twelves, Klaas Hoekman, A. Bowman et al. · European Journal of Cancer · 2003 · 83 citations

Medicine, Pharmacology, Solid Tumours +6

TELEMAM: A cluster randomised trial to assess the use of telemedicine in multi-disciplinary breast cancer decision making

I.H. Kunkler, R.J. Prescott, R.J. Lee et al. · European Journal of Cancer · 2007 · 57 citations

Nursing, Medical Decision Making, Health Policy +11

Prognostic Significance of CA 125 and TPS Levels after 3 Chemotherapy Courses in Ovarian Cancer Patients

A. van Dalen, Judith Favier, Alexander Burges et al. · Gynecologic Oncology · 2000 · 56 citations

Ca 125, Medicine, Gynecology +8